Definition: Vasculitis is the inflammation of blood vessels, which can result in damage to the vessel walls, narrowing, or occlusion, leading to reduced blood flow and potential organ damage.
Classification:
Large vessel vasculitis: Affects large arteries (e.g., giant cell arteritis, Takayasu arteritis).
Small vessel vasculitis: Affects small arteries, capillaries, and venules (e.g., granulomatosis with polyangiitis, microscopic polyangiitis, Henoch-Schönlein purpura).
Etiology:
Idiopathic in most cases but can be secondary to infections, autoimmune disorders, medications, or malignancies.
Clinical Features
General Symptoms:
Systemic symptoms such as fever, fatigue, weight loss, and myalgia.
Organ-specific symptoms depend on the type of vasculitis and the affected organs.
Increased ESR and CRP indicate systemic inflammation.
Autoantibodies: ANCA (positive in GPA, MPA), elevated IgA (in HSP).
Basic lab results may show anemia, leukocytosis, and elevated creatinine in renal involvement.
Imaging:
Angiography: Useful in diagnosing medium and large vessel vasculitis by detecting aneurysms or stenosis.
CT/MRI: Helps in identifying structural changes in the affected vessels.
Biopsy:
Considered the definitive method for diagnosing small vessel vasculitis.
Treatment
Corticosteroids:
High-dose corticosteroids are the first-line treatment for most vasculitis types.
Gradual tapering is necessary after symptom control.
Immunosuppressive Therapy:
Cyclophosphamide, methotrexate, azathioprine for severe or refractory cases.
Rituximab: Often used in ANCA-associated vasculitis (GPA, MPA).
Special Treatments:
IVIG: Used for Kawasaki disease to prevent coronary artery complications.
Tocilizumab: Approved for use in giant cell arteritis.
Essential Points
Vasculitis is classified based on the size of the vessels involved (large, medium, small).
Diagnosis is based on clinical findings, lab results (e.g., ANCA, ESR), imaging, and biopsy when needed.
Early treatment with corticosteroids and immunosuppressants can prevent severe organ damage.
Rapid identification and management are essential in diseases like giant cell arteritis (risk of blindness) and Kawasaki disease (risk of coronary artery aneurysms).